CVNZ.F Stock Overview
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Comvita Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$1.56 |
| 52 Week High | NZ$2.09 |
| 52 Week Low | NZ$1.56 |
| Beta | 0.50 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -15.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVNZ.F | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | 4.1% | 1.2% |
| 1Y | n/a | -26.0% | 24.9% |
Return vs Industry: Insufficient data to determine how CVNZ.F performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how CVNZ.F performed against the US Market.
Price Volatility
| CVNZ.F volatility | |
|---|---|
| CVNZ.F Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CVNZ.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CVNZ.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 595 | David Banfield | www.comvita.co.nz |
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, gourmet honey, and elixirs and lozenges, as well as oral care and kids health products. It also provides solutions for digestive health, skin health, heart and metabolic health, and immunity.
Comvita Limited Fundamentals Summary
| CVNZ.F fundamental statistics | |
|---|---|
| Market cap | US$86.24m |
| Earnings (TTM) | US$2.20m |
| Revenue (TTM) | US$133.74m |
39.6x
P/E Ratio0.7x
P/S RatioIs CVNZ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVNZ.F income statement (TTM) | |
|---|---|
| Revenue | NZ$225.43m |
| Cost of Revenue | NZ$96.87m |
| Gross Profit | NZ$128.56m |
| Other Expenses | NZ$124.85m |
| Earnings | NZ$3.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.053 |
| Gross Margin | 57.03% |
| Net Profit Margin | 1.64% |
| Debt/Equity Ratio | 41.9% |
How did CVNZ.F perform over the long term?
See historical performance and comparison